Immobilized neuroglobin scavenges carbon monoxide from circulating carboxyhemoglobin
Preprint
Abstract
Carbon monoxide (CO) poisoning is responsible for around 50,000 emergency department visits per year in the U.S. alone. With the present standard of care, persistent neurological sequelae occur in ∼30-40% of severe CO poisoning cases. Currently, there is no available targeted molecular antidote for CO poisoning. In previous work, we have developed an antidotal therapy for CO poisoning based on an engineered hemeprotein, human neuroglobin (Ngb-H64Q-CCC). Intravenous infusion of Ngb-H64Q-CCC removes CO from the circulating red blood cells and improves survival in a lethal CO-poisoning mouse model. However, the infusion of heme-containing proteins has inherent heme toxicity risks that may limit the dose that can be used safely without liver or kidney toxicity. In order to overcome these problems, we have investigated the development of immobilized Ngb in a solid matrix. This approach allows for the development of a CO removal system using an extracorporeal blood circulating system coupled with a stationary matrix with immobilized Ngb-H64Q-CCC. Such system avoids drug infusion and possible organ injury, allows for antidote recycling, and provides advantages for storage and handling of the antidote. By assessing the efficacy of Ngb-H64Q-CCC immobilized through different linkage strategies, we have identified N-hydroxysuccinimide agarose resin as a viable stationary phase. The immobilized protein shows preserved heme redox activity, can be chemically reduced/oxidized for activation/CO release purposes, and retains its CO removal capacity after successive regeneration cycles. We expect that this novel approach will advance the development of new scavenger-based therapies for CO poisoning.Keywords
Funding Information
- Clinical and Translational Science Institute, University of Pittsburgh (Collaboration in HEalth Sciences and EnginERing Startup (CHEERS) Program)
This publication has 40 references indexed in Scilit:
- Veno‐venous extracorporeal blood phototherapy increases the rate of carbon monoxide (CO) elimination in CO‐poisoned pigsLasers in Surgery and Medicine, 2021
- Lessons from the post-genomic era: Globin diversity beyond oxygen binding and transportRedox Biology, 2020
- Extracorporeal carbon dioxide removal (ECCO2R) in patients with acute respiratory failureIntensive Care Medicine, 2017
- Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDSIntensive Care Medicine, 2013
- Immobilized carbonic anhydrase on hollow fiber membranes accelerates CO2 removal from bloodJournal of Membrane Science, 2012
- Theoretical and Experimental Analysis of Anti-A Antibody Capture in Novel Integrated Bead and Hollow Fiber ModulesAnnals of Biomedical Engineering, 2010
- Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and DeathJAMA, 2008
- Renal Replacement Therapy in Patients With Acute Renal FailureJAMA, 2008
- Myocardial Injury and Long-term Mortality Following Moderate to Severe Carbon Monoxide PoisoningJAMA, 2006
- A new method for the determination of ligand dissociation rate constant of carboxyhemoglobinBiochemical and Biophysical Research Communications, 1975